We are live on ! Find out more
XT

XTX Topco Portfolio holdings

AUM $5.75B
1-Year Est. Return 30.56%
This Fund
S&P 500
This Quarter Est. Return
+0.17%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$3.81B
AUM Growth
+$1.88B
Cap. Flow
+$1.94B
Cap. Flow %
50.99%
Top 10 Hldgs %
5.52%
Holding
3,983
New
1,493
Increased
1,108
Reduced
652
Closed
727

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$25.6M
2
JPM icon
JPMorgan Chase
JPM
+$21.7M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$19.7M
4
KR icon
Kroger
KR
+$17.9M
5
TMUS icon
T-Mobile US
TMUS
+$15.8M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$11.3M
2
TMO icon
Thermo Fisher Scientific
TMO
+$8.42M
3
BMY icon
Bristol-Myers Squibb
BMY
+$8.34M
4
CSCO icon
Cisco
CSCO
+$8.02M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$8.01M

Sector Composition

Rank Sector Weight
1 Financials 16.84%
2 Technology 16.54%
3 Industrials 11.45%
4 Healthcare 11.32%
5 Consumer Discretionary 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IAG icon
1926
IAMGOLD
IAG
$8.05B
$354K 0.01%
21,483
-125,456
-85% -$1.77M
SLDP icon
1927
Solid Power
SLDP
$450M
$354K 0.01%
+83,349
New +$460K
TPVG icon
1928
TriplePoint Venture Growth BDC
TPVG
$184M
$354K 0.01%
+54,137
New +$324K
FNGD icon
1929
MicroSectors FANG+ Index -3X Inverse Leveraged ETNs due January 8, 2038
FNGD
$475M
$353K 0.01%
+6,706
New +$326K
MNTN
1930
MNTN Inc
MNTN
$707M
$353K 0.01%
+29,556
New +$426K
AVXL icon
1931
Anavex Life Sciences
AVXL
$231M
$353K 0.01%
99,058
+17,356
+21% +$106K
VIAV icon
1932
Viavi Solutions
VIAV
$7.95B
$352K 0.01%
19,774
-9,643
-33% -$156K
SHBI icon
1933
Shore Bancshares
SHBI
$820M
$351K 0.01%
19,878
+9,782
+97% +$164K
PSBD icon
1934
Palmer Square Capital BDC
PSBD
$303M
$351K 0.01%
+28,792
New +$352K
OPFI icon
1935
OppFi
OPFI
$813M
$350K 0.01%
+33,467
New +$339K
ATI icon
1936
ATI
ATI
$24.3B
$349K 0.01%
+3,037
New +$296K
SPXS icon
1937
Direxion Daily S&P 500 Bear 3x ETF
SPXS
$362M
$348K 0.01%
+9,825
New +$359K
ZURA icon
1938
Zura Bio
ZURA
$504M
$348K 0.01%
+66,453
New +$263K
GRDN
1939
Guardian Pharmacy Services
GRDN
$2.6B
$348K 0.01%
+11,564
New +$327K
LBRDA icon
1940
Liberty Broadband Class A
LBRDA
$4.89B
$348K 0.01%
7,201
-590
-8% -$30.6K
JILL icon
1941
J. Jill
JILL
$274M
$347K 0.01%
+25,326
New +$383K
MIST icon
1942
Milestone Pharmaceuticals
MIST
$129M
$347K 0.01%
171,960
-15,341
-8% -$33K
IGR
1943
CBRE Global Real Estate Income Fund
IGR
$719M
$347K 0.01%
+79,220
New +$373K
PTA icon
1944
Cohen & Steers Tax-Advantaged Preferred Securities & Income Fund
PTA
$1.03B
$347K 0.01%
+17,953
New +$354K
TPH
1945
DELISTED
Tri Pointe Homes
TPH
$346K 0.01%
11,006
-48,867
-82% -$1.59M
LZ icon
1946
LegalZoom.com
LZ
$1.45B
$346K 0.01%
34,810
-56,964
-62% -$565K
MRSN
1947
DELISTED
Mersana Therapeutics
MRSN
$346K 0.01%
+11,948
New +$227K
QLD icon
1948
ProShares Ultra QQQ
QLD
$11.7B
$345K 0.01%
+4,897
New +$347K
ALKS icon
1949
Alkermes
ALKS
$8.11B
$345K 0.01%
12,322
-32,306
-72% -$968K
NEXT icon
1950
NextDecade
NEXT
$1.68B
$343K 0.01%
+65,150
New +$389K
76 77
78
79 80

Similar funds

HW
Hancock Whitney Gulfport, Mississippi $5.75B AUM 24.3% 1-Year Est. Return
AAM
Alphadyne Asset Management New York $5.76B AUM 22.07% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $5.76B AUM 24.57% 1-Year Est. Return
SAM
Scopus Asset Management New York $5.77B AUM 36.85% 1-Year Est. Return
PP
Peconic Partners New York $5.78B AUM 127.23% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

XTX Topco's Q4 2025 Portfolio in Review

As of Q4 2025, XTX Topco held 3,983 positions worth $3.81B, up 98% from $1.93B the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.

XTX Topco deployed $1.94B of net new capital in Q4 2025, opening 1,493 new positions and adding to 1,108 existing holdings. Its largest new stake was T-Mobile US: 74,738 shares worth $15.2M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $8.34M trimmed.

  • XTX Topco's largest Q4 2025 buy was T-Mobile US: 74,738 shares worth $15.2M.
  • XTX Topco added most to Procter & Gamble in Q4 2025, an estimated $25.6M increase.
  • XTX Topco's biggest Q4 2025 reduction was Bristol-Myers Squibb, cutting an estimated $8.34M.
  • XTX Topco fully exited Johnson & Johnson in Q4 2025, selling an estimated $11.3M.
  • XTX Topco's ten largest holdings make up 5.5% of its $3.81B portfolio in Q4 2025.
  • XTX Topco opened 1,493 new positions and closed 727 in Q4 2025.
  • XTX Topco's portfolio value rose 98% quarter-over-quarter to $3.81B.

Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.